US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

5  6  7  8    10    12  13  14  
Complete 2013-14 Induce Pluripotent Stem Cell Industy Report
2/1/2014 | published by: BioInformant Worldwide, L.L.C.
... replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from ...  |  read more...
$3,495.00
Worldwide Biotech February 2014
2/1/2014 | published by: Worldwide Videotex
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry.  |  read more...
$25.00
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
2/1/2014 | published by: Current Partnering
... and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals. The majority of deals are where the ...  |  read more...
$2,995.00
Biotech Financial Reports February 2014
2/1/2014 | published by: Worldwide Videotex
BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements.  |  read more...
$25.00
Global Next Generation Sequencing Market: Trends & Opportunities (2013-2018)
2/1/2014 | published by: Daedal Research
... market. The report also provides detailed analysis of the global next generation sequencing market, the Sanger Sequencing market and provides specific focus on the clinical diagnostic opportunities of the NGS technology. The report also profiles ...  |  read more...
$800.00
Novartis Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying ...  |  read more...
$995.00
Nektar Therapeutics Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... the information you require to better understand Nektar Therapeutics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up ...  |  read more...
$995.00
Genetic Disorders Partnering Terms and Agreements
2/1/2014 | published by: Current Partnering
... are discovery, preclinical or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. ...  |  read more...
$2,995.00
Cell Therapy Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
$1,495.00
Ipsen Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
LFB Group Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... information you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date ...  |  read more...
$995.00
Big Biotech Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2013’s dealmaking ...  |  read more...
$1,495.00
Gilead Sciences Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
$995.00
Alkermes Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Alkermes and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Medivation Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Intermune and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Elan Partnering 2009-2014
2/1/2014 | published by: Current Partnering
... you require to better understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
$995.00
Discovery Stage Partnering Terms and Agreements in Pharma and Biotech
2/1/2014 | published by: Current Partnering
... and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the ...  |  read more...
$3,295.00
Clinical Stage Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
$1,495.00
Public Health Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
$1,495.00
Antibody Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
Genomics Deals and Alliances of 2013
2/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
$1,495.00
Genentech, Inc. - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Genentech, Inc.’s corporate ...  |  read more...
$1,500.00
Freedonia Focus on Enzymes: United States
1/31/2014 | published by: Freedonia Focus Reports
... nucleases, and other enzymes. Total demand is also segmented by market as follows: biofuel production, food and beverage, cleaning product, other industrial markets, research and biotechnology, and other specialty markets. To illustrate historical trends, total ...  |  read more...
$600.00
Generex Biotechnology Corporation - Product Pipeline Review - 2014
1/31/2014 | published by: Global Markets Direct
... focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct’s proprietary databases, ...  |  read more...
$1,500.00
MediPoint: Bone Grafts and Substitutes - South American Analysis and Market Forecasts
1/31/2014 | published by: GlobalData
... has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents ...  |  read more...
$4,450.00
5  6  7  8    10    12  13  14  
 
Our Clients